Craig Overpeck[email protected]InfectiousAccelerate builds case for phenotypic susceptibility testingAccelerate Pheno decreases the length of time for organism detection, susceptibility results, and antibiotic change for patients with bacteremia, according to the Tucson, AZ-based company.October 2, 2019Page 1 of 1Top StoriesBusiness InsightsTexas lab owner accused of $79M RPP fraud schemeThe DOJ implicated a Texas clinical laboratory owner and operator in respiratory pathogen panel testing fraud scheme.Research and DevelopmentRevvity broadens work in newborn testing for NHS EnglandRegulatory ApprovalRoche gets CE Mark for ovarian cancer CDx testSequencingAMP reviews pitfalls of NGS testing for SARS-CoV-2Sponsor ContentBody composition in patients treated with Ozempic